Shay Capital’s Cano Health, Inc. CANO Stock Holding History

Shay Capital’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,370	Closed	-$1.19M	–	433
2022 Q3	$1.19M	Buy	+1,370	New	+$859K	0.26%	76

Other funds holding CANO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Shay Capital's CANO Position: Q4 2023 in Review

Shay Capital sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 504 shares — an estimated $12.8K sold.

Shay Capital first reported a position in CANO in Q4 2020 and held it in 7 quarters. The position peaked at $3.11M in Q4 2020. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

Shay Capital reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
Shay Capital sold 504 Cano Health, Inc. shares in Q4 2023, an estimated $12.8K.
Shay Capital first reported a position in Cano Health, Inc. in Q4 2020 and held it in 7 quarters.
Shay Capital's Cano Health, Inc. position peaked at $3.11M in Q4 2020.
50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Shay Capital's 13F filing for Q4 2023, filed 14 Feb 2024.